Guillermo Torre-Amione
Independent ChairmanDr. Guillermo Torre-Amione, MD, PhD, is Independent Director of Cardiol Therapeutics Inc. since August 20, 2018 and has been its Independent Chairman since July 07, 2021. Dr. Torre-Amione is chief of the Heart Failure Division and medical director of Cardiac Transplantation at the Houston Methodist DeBakey Heart #38; Vascular Center, where he divides his time between an active clinical practice and heart failure research. He also is a senior member at The Methodist Hospital Research Institute, full professor of medicine at the Weill Cornell Medical College of Cornell University, New York, and, more recently, became President of TecSalud, an academic medical center and medical school of the Instituto Tecnol#243;gico y de Estudios Superiores de Monterrey (ITESM) in Mexico. Dr. Torre-Amione spearheads the Gene and Judy Campbell Laboratory for Cardiac Transplant Research, where his primary areas of research include heart failure, cardiac transplantation, and the role of the immune response in modulating the progression of heart failure. He initiated a series of clinical studies that led to an FDA-approved phase II clinical trial of neurostimulation in heart failure, a novel approach to the treatment of patients with advanced heart failure. He divides his time between his clinical and academic activities at The Methodist Hospital and ITESM. Prior to being appointed to Cardiol's Board of Directors, Dr. Torre-Amione was a member of the Company's Scientific Advisory Board. Dr. Torre-Amione received his medical degree from the ITESM and a doctorate degree in immunology from the University of Chicago. He has published more than 170 manuscripts in peer-reviewed journals.
Positions
- Company NameCardiol Therapeutics Inc.Stock CodeCRDLPositionIndependent ChairmanColleagues
- DGDavid G. ElsleyPresident, CEO & Director
- CJChristopher J. WaddickCFO, Corporate Secretary & Director
- BLBernard LimChief of Operations
- AWAndrew Warwick HamerChief Medical Officer and Head of Research & Development
- TBTrevor BurnsInvestor Relations
- JMJennifer M. ChaoIndependent Director
- TLTeri LoxamIndependent Director
